Skip to main content
. 2024 Aug 29;17:3217–3226. doi: 10.2147/DMSO.S472174

Table 1.

The Blood Glucose Control of T2DM Patients Undergoing IDegLira Treatment

Blood Glucose Control
Relatively Ideal Relatively Not Ideal Not Ideal Relatively Poor
(HbA1c≤7%) (7%<HbA1c≤8%) (8%<HbA1c≤9%) (HbA1c>9%)
59/80 15/80 4/80 2/80
73.75% 18.75% 5% 2.5%